HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3K/Akt pathway.

AbstractBACKGROUND & AIMS:
Hepatic ischemia and reperfusion (I/R) injury is a major complication of liver transplantation, hepatic resection and trauma. Helium preconditioning (HPC) exerts protection against ischemic stress. We investigated potential beneficial effects of HPC on I/R-induced liver injury and investigated mechanisms underlying HPC-induced protection.
METHODS:
We employed a model of segmental warm hepatic I/R on BALB/c mice. Serum ALT was measured and livers were analysed by histology, RT-PCR and western blot. HPC was induced by inhalation of a 70% helium/30% oxygen mixture for three 5-min periods, interspersed with three 5-min washout periods by room air. We tested which component of HPC (the helium/air mixture inhalation, the air room gap, or the interaction between these two factors) is protective.
RESULTS:
We found that HPC caused a significant increase in Akt phosphorylation in hepatocytes. The HPC-induced Akt phosphorylation resulted in decreased hepatocellular injury and improved survival rate of the treated animals. PI3K inhibitors abolished HPC induced effects. HPC-induced Akt phosphorylation affected expression of its downstream molecules. The effects of HPC on the PI3K/Akt pathway were attenuated by adenosine A2A receptor blockade, but could be re-established by PTEN inhibition. We demonstrated that the interaction of helium/air breathing and air gaps is responsible for the observed effects of HPC.
CONCLUSIONS:
HPC may be a promising strategy leading to a decrease in I/R induced liver injury in clinical settings. Additionally, the PI3K/Akt pathway plays an essential role in the protective effects of HPC in hepatic I/R injury.
AuthorsRongjia Zhang, Ling Zhang, Anatol Manaenko, Zhouheng Ye, Wenwu Liu, Xuejun Sun
JournalJournal of hepatology (J Hepatol) Vol. 61 Issue 5 Pg. 1048-55 (Nov 2014) ISSN: 1600-0641 [Electronic] Netherlands
PMID24972044 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 European Association for the Study of the Liver. All rights reserved.
Chemical References
  • Adenosine A2 Receptor Antagonists
  • NF-kappa B
  • Triazines
  • Triazoles
  • ZM 241385
  • Helium
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • PTEN Phosphohydrolase
  • Pten protein, mouse
Topics
  • Adenosine A2 Receptor Antagonists (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Disease Models, Animal
  • Helium (therapeutic use)
  • Ischemic Preconditioning (methods)
  • Liver (drug effects, injuries, metabolism)
  • Liver Transplantation (adverse effects, methods)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (metabolism)
  • PTEN Phosphohydrolase (antagonists & inhibitors)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Reperfusion Injury (metabolism, pathology, prevention & control)
  • Signal Transduction
  • Transplantation Conditioning (methods)
  • Triazines (pharmacology)
  • Triazoles (pharmacology)
  • Warm Ischemia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: